SRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor Properties.
Warren MC, Matissek S, Rausch M, Panduro M, Hall RJ, Dulak A, Brennan D, Das Yekkirala S, Koseoglu S, Masia R, Yang Y, Reddy N, Prenovitz R, Strand J, Zaidi T, Devereaux E, Foissac CJ, Stagg J, Lee BH, Holland P, Palombella VJ, Lake AC.
Warren MC, et al. Among authors: matissek s.
Immunohorizons. 2023 May 1;7(5):366-379. doi: 10.4049/immunohorizons.2200089.
Immunohorizons. 2023.
PMID: 37219538
Free PMC article.